The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies
The launch saw the presence of senior clinicians and leadership from the Manipal Hospitals network
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
A brand from Opella will be part of the official NASA astronaut formulary
The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care
No adverse events reported; recall involves 5 mg 500-count bottles in the US market
The three-day conference is expected to bring together more than 3,000 physiotherapists, clinicians, researchers, academicians, and students
The solution integrates key molecular cloning methods—including Golden Gate, Gibson assembly, and restriction/ligation—alongside primer design, Sanger sequencing analysis, and protein translation in a single application
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
The study is a global, randomized, double-blind, placebo-controlled trial testing GLM101 for phosphomannomutase 2 congenital disorder of glycosylation
Subscribe To Our Newsletter & Stay Updated
